anmelden
OMX Nordic 40
2.711,69
PKT
-3,84
PKT
-0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.06.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.06.20 | Hennes Mauritz (H M, H&M) overweight | JP Morgan Chase & Co. | |
| 26.06.20 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 26.06.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 26.06.20 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 25.06.20 | Nokia buy | Deutsche Bank AG | |
| 25.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.06.20 | Novo Nordisk Neutral | Oddo BHF | |
| 22.06.20 | AstraZeneca Reduce | Oddo BHF | |
| 22.06.20 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 19.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 19.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.06.20 | A.P. Moeller - Maersk A-S (B) neutral | Jefferies & Company Inc. | |
| 18.06.20 | Volvo (B) buy | Jefferies & Company Inc. | |
| 17.06.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 17.06.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 16.06.20 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 16.06.20 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 15.06.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 15.06.20 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.06.20 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 15.06.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 11.06.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 10.06.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.06.20 | Volvo (B) Conviction Buy | Goldman Sachs Group Inc. | |
| 09.06.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 08.06.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.06.20 | AstraZeneca Sell | UBS AG | |
| 08.06.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 05.06.20 | Novo Nordisk Neutral | UBS AG |
